IBRANCE

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 777ff2ea394d862c
Drug Approval Canada Name: IBRANCE
Product Name: IBRANCE
Status: Marketed
Status Date: 2020-09-21
Original Market Date: 2020-09-21
Din: 02493543
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EF01 PALBOCICLIB
Atc Name: l 01 ef 01
Aig Number: 0157970002
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

PALBOCICLIB

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

777ff2ea394d862c

Type

Standard